Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarah Jacques
Institution:
University of Colorado Anschutz
Observed institution:
University of Colorado Anschutz
ORCID:
0009-0007-2269-4831
Observed ORCID:
0009-0007-2269-4831
OpenAlex ID:
A5103215728
Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins
2023
·
Yue Li
, Sarah Jacques
, et al.
·
Nature Nanotechnology
·
56
PDF
Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors
2025
·
Yue Li
, Sarah Jacques
, et al.
·
Science Advances
·
23
PDF
Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin
2024
·
Yue Li
, Utibeabasi Ettah
, et al.
·
Molecular Pharmaceutics
·
19
PDF
How Reproducible Is Feraheme® (Ferumoxytol Injection)? Comparison of Size, Zeta Potential, and Complement Activation of Different Batches over 15 Years
2024
·
Utibeabasi Ettah
, Sarah Jacques
, et al.
·
Journal of Nanotheranostics
·
2
PDF
Bioorthogonal tuning of nanosurface opsonisation via click coupling of a complement fusion protein inhibitor
2026
·
Sarah Jacques
, Hanmant Gaikwad
, et al.
·
Chemical Communications
·
1
PDF
Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies
2025
·
Shashikant Ray
, Sarah Jacques
, et al.
·
Molecular Pharmaceutics
Show more works
View as search
Works count:
6
Citation count:
101
H-index:
3
I10-index:
3
Year
Topic
Type